PMID: 3750137Sep 13, 1986Paper

Dipyrone-containing analgesics

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
J Moffatt

Abstract

Analgesics containing dipyrone continue to be available throughout Africa, including South Africa and Zimbabwe. Although an effective analgesic and antipyretic, dipyrone may cause severe side-effects, including agranulocytosis. The mechanism of this hypersensitivity reaction has been well documented, and many reports of agranulocytosis associated with dipyrone use have been published. Use of this drug has been prohibited or restricted in several countries. Dipyrone is known by a variety of official names, which may contribute to confusion in deciding whether a particular preparation contains this drug. The prescribing information contained in the Monthly Index of Medical Specialities (MIMS) (South Africa) and the MIMS Desk Reference is inadequate for some of the products available, although the package inserts do provide more detailed information. The continued use of these products is difficult to justify when safer alternatives are available.

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

Pediatrics International : Official Journal of the Japan Pediatric Society
Jesmin PermalaAsrul Akmal Shafie
Drug Safety : an International Journal of Medical Toxicology and Drug Experience
Ferenc BánhidyAndrew E Czeizel
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Stanisław Maj, Piotr Centkowski
Journal of Toxicology. Clinical Toxicology
Yedidia Bentur, Omri Cohen
© 2021 Meta ULC. All rights reserved